CDERLearn
Best Practices for Communication Between FDA and IND Sponsors During Drug Development: The course describes best practices and procedures for timely, transparent, and effective communications between investigational new drug application (IND) sponsors and FDA at critical junctures in drug development.
CDERLearn in the Center for Drug Evaluation and Research (CDER) offers a variety of learning opportunities for healthcare professionals, industry, consumers, and academia. The goal is to create a body of educational and information modules about human drug regulation and activities. CDERLearn is a way to share FDA expertise in specific subject areas to further instruct the public about the many ways CDER protects and promotes public health.
Education Series
Information Series
Learn more on FDA's Training and Continuing Education webpage.
Contact Us
Toll Free
(855) 543-3784, or
(301) 796-3400
druginfo@fda.hhs.gov
Human Drug Information
Division of Drug Information (CDER)
Office of Communications
Feedback Form
10001 New Hampshire Avenue
Hillandale Building, 4th Floor
Silver Spring, MD 20993